{"product_id":"washington-university-school-of-medicine-in-st-louis-7th-annual-ibd-center-multidisciplinary-conference-2025","title":"Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025","description":"\u003ch3 class=\"product_title entry-title\"\u003eWashington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025\u003c\/h3\u003e\r\n\u003cstrong\u003e+ Include: 19 Videos (.mp4) + 19 Audios (.mp3) + 19 Subtitles (.vtt) + 14 PDFs, size: 3.82 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: gastroenterologists and multidisciplinary IBD\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025 provides an advanced clinical review of Inflammatory Bowel Disease (IBD). The program covers the strategic positioning of medical therapies, innovative approaches for refractory disease, multidisciplinary management of complex cases, and the integration of adjunctive dietary and behavioral interventions.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"420\"\u003eCourse Date: \u003c\/b\u003eSaturday, March 8, 2025\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"3\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate the optimal positioning of advanced medical therapies, JAK inhibitors, and combination treatments for Crohn’s Disease and Ulcerative Colitis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,1,0\"\u003eAssess novel approaches for refractory IBD, including the potential role of stem cell transplantation and non-formulary agents.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,2,0\"\u003eFormulate multidisciplinary management plans for complex presentations, such as stricturing disease and acute severe Ulcerative Colitis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,3,0\"\u003eIntegrate adjunctive treatments, including specific dietary protocols, body weight modulation, and mindfulness, into comprehensive IBD care.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,4,0\"\u003eApply updated clinical guidelines for dysplasia screening, scoping practices, and post-operative recurrence prevention in IBD patients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audienc\u003c\/h2\u003e\r\nBest for gastroenterologists and multidisciplinary IBD teams who want updates on medical therapies, refractory disease, and diet interventions.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003col start=\"1\" data-path-to-node=\"8\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,0,0\"\u003ePositioning Medical Therapies in Crohn’s Disease\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,1,0\"\u003eDebate – Second Line Therapy in Crohns Disease after an Anti-TNF-a – Upadacitinib vs. IL-23\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,2,0\"\u003ePositioning Medical Therapies in Ulcerative Colitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,3,0\"\u003eQ\u0026amp;A – Using a JAK inhibitor before anti-TNF, Use of Upadacitinib in France vs. U.S.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,4,0\"\u003eNovel Approaches to Address Refractory IBD – Stem Cell Transplantation\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,5,0\"\u003eBreaking the Therapeutic Ceiling in IBD through Innovative Trial Designs\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,6,0\"\u003eQ\u0026amp;A – Genetic Testing for Stem Cell Transplantation, Minimizing the Risk of Placebo for Patients Entering Clinical Trials…\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,7,0\"\u003eIBD Case-Based Discussion on Stricturing Disease – Radiologic, Surgical, and Endoscopic Approaches\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,8,0\"\u003eDebate – Role of JAK inhibitors vs. Surgery in the TNFi-exposed Patient with Acute Severe Ulcerative Colitis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,9,0\"\u003eQ\u0026amp;A – Current Recommendations for Prevention of Recurrence of Crohn’s \u0026amp; UC, Role of MR Enterography is post Cro…\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,10,0\"\u003eCombined Advanced Therapies for IBD – Are We Ready for Prime Time\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,11,0\"\u003eNutrition as Therapy for Pediatric IBD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,12,0\"\u003eDiet in Adults with IBD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,13,0\"\u003eModulation of Body Weight and Mass as Adjunctive Approaches in IBD Patients\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,14,0\"\u003eQ\u0026amp;A – Will Kids Actually Drink Elemental Formulas, Safety of GLP-1 in Patients with IBD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,15,0\"\u003eBehavioral Approaches Complimentary with Medical Therapies – Mindfulness and IBD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,16,0\"\u003eNon-Formulary Agents in Inflammatory Bowel Disease\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,17,0\"\u003eApproach to Dysplasia in IBD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,18,0\"\u003eQ\u0026amp;A – When Do You Stop Scoping Patients, Efficacy of Tacrolimus Suppositories\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954671521890,"sku":"MED-AMB07932","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Washington-University-School-of-Medicine-in-St.-Louis-7th-Annual-IBD-Center-Multidisciplinary-Conference-2025.png?v=1779382156","url":"https:\/\/meducourse.com\/products\/washington-university-school-of-medicine-in-st-louis-7th-annual-ibd-center-multidisciplinary-conference-2025","provider":"Meducourse","version":"1.0","type":"link"}